Home/Filings/4/0001638727-18-000002
4//SEC Filing

DOCHERTY JOHN MARTIN 4

Accession 0001638727-18-000002

CIK 0001348362other

Filed

Aug 6, 8:00 PM ET

Accepted

Aug 7, 3:05 PM ET

Size

10.6 KB

Accession

0001638727-18-000002

Insider Transaction Report

Form 4
Period: 2010-01-20
DOCHERTY JOHN MARTIN
DirectorPresident
Transactions
  • Award

    Common Shares

    2018-08-03$1.24/sh+91,250$113,1501,585,750 total(indirect: Private holding company)
  • Award

    Common Shares

    2018-08-03$1.32/sh+182,500$240,9001,494,500 total(indirect: Private holding company)
Holdings
  • Common Shares

    (indirect: Private holding company)
    1,312,000
  • Stock Options

    Exercise: $1.53From: 2018-05-31Exp: 2023-05-31Common Shares (400,000 underlying)
    1,250,000
  • Stock Options

    Exercise: $0.09From: 2015-03-26Exp: 2020-03-26Common Shares (550,000 underlying)
    550,000
  • Stock Options

    Exercise: $0.11From: 2016-04-15Exp: 2021-04-15Common Shares (300,000 underlying)
    850,000

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1
  • filerCIK 0001638727

Filing Metadata

Form type
4
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 3:05 PM ET
Size
10.6 KB